Stock Events

Stock Events

Nanobac Pharmaceuticals 

$0.000001
4
-$0.00-99%Monday 12:34

Statistics

Day High
0.000001
Day Low
0.000001
52W High
0.0001
52W Low
0.000001
Volume
1,000
Avg. Volume
0
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Pfizer
PFE
Mkt Cap173.95B
Pfizer is a global pharmaceutical company that competes with Nanobac Pharmaceuticals in the development of medications for various diseases, including those that Nanobac targets with its nanotechnology-based therapies.
Merck
MRK
Mkt Cap368.89B
Merck is a leading pharmaceutical company that develops vaccines and medicines for infectious diseases, directly competing with Nanobac Pharmaceuticals' focus on innovative treatments.
Johnson & Johnson
JNJ
Mkt Cap657.68B
Johnson & Johnson, through its pharmaceutical division, develops a wide range of healthcare products that compete with Nanobac Pharmaceuticals in the areas of drug development and nanomedicine.
Gilead Sciences
GILD
Mkt Cap179.47B
Gilead Sciences is known for its antiviral drugs and competes with Nanobac Pharmaceuticals in the development of treatments for viral infections, leveraging advanced technologies.
AMGEN
AMGN
Mkt Cap217.9B
Amgen focuses on biologic medicines, including those for infectious diseases, which puts it in direct competition with Nanobac Pharmaceuticals' approach to drug development.
Abbvie
ABBV
Mkt Cap521.11B
AbbVie operates in similar therapeutic areas as Nanobac Pharmaceuticals, including significant investments in research and development for innovative treatments.
Bristol-Myers Squibb
BMY
Mkt Cap127.71B
Bristol Myers Squibb has a diverse portfolio of prescription medications, competing with Nanobac Pharmaceuticals in the development of novel therapies for various diseases.
Novartis
NVS
Mkt Cap268B
Novartis is a global healthcare company that competes with Nanobac Pharmaceuticals in researching and developing advanced therapeutic options for patients.
Roche
RHHBY
Mkt Cap334.28B
Roche Holding AG is involved in the development of pharmaceuticals and diagnostics, competing with Nanobac Pharmaceuticals in the innovation of treatments for complex diseases.
Astrazeneca
AZN
Mkt Cap289.48B
AstraZeneca is a biopharmaceutical company that competes with Nanobac Pharmaceuticals in the development of drugs for several therapeutic areas, including those targeted by Nanobac.

About

Nanobac Pharmaceuticals, Incorporated is dedicated to advancing human health through the creation and refinement of products and services designed for the identification and management of calcifying nanoparticles (CNPs). The company's offerings include the production and sale of in vitro diagnostic (IVD) kits, which encompass assays, antibodies, and reagents specifically developed for detecting CNPs. Notably, their diagnostic assays include NANO-CAPTURE and NANO-SERO. Furthermore, Nanobac engages in research and clinical studies focused on various urological diseases—such as chronic prostatitis/chronic pelvic pain syndrome, kidney stones, and polycystic kidney diseases—as well as cardiovascular ailments. Established in 1994 and headquartered in Tampa, Florida, the company operated as HealthCentrics Inc. until its name change to Nanobac Pharmaceuticals, Incorporated in December 2002.
Show More
CEO
John Stanton
Employees
1
Country
United States
ISIN
US63007M1027

Listings

OTC Link
US
NNBP

0 Comments

Share your thoughts

FAQs

What is Nanobac Pharmaceuticals stock price today?▼
The current price of NNBP is $0.00 USD — it has decreased by -99% in the past 24 hours. Watch Nanobac Pharmaceuticals stock price performance more closely on the chart.
What is Nanobac Pharmaceuticals stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange Nanobac Pharmaceuticals stocks are traded under the ticker NNBP.
Is Nanobac Pharmaceuticals stock price growing?▼
NNBP stock has risen by +0% compared to the previous week, the month change is a +0% rise, over the last year Nanobac Pharmaceuticals has showed a +0% increase.
How many employees does Nanobac Pharmaceuticals have?▼
As of November 2, 2026, the company has 1 employees.
In which sector is Nanobac Pharmaceuticals located?▼
Nanobac Pharmaceuticals operates in the Health & Wellness sector.
When did Nanobac Pharmaceuticals complete a stock split?▼
Nanobac Pharmaceuticals has not had any recent stock splits.
Where is Nanobac Pharmaceuticals headquartered?▼
Nanobac Pharmaceuticals is headquartered in Tampa, United States.